insights_auto
Why is INO down 16.21%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.22
arrow_downward
-16.21%(-0.24) 1D
$1.24
arrow_upward
+2.06% (+0.025)bedtimeAfter hours
Closed: Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.12
High
$1.27
Low
$1.07
Mkt. cap
125.63M
Avg. vol.
16.17M
Volume
39.42M
52-wk high
$2.72
52-wk low
$0.56
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
Open
$1.12
High
$1.27
Low
$1.07
Mkt. cap
125.63M
Avg. vol.
16.17M
Volume
39.42M
52-wk high
$2.72
52-wk low
$0.56
EPS
-$1.17
Beta
1.71
Shares outstanding
103.40M
No. of employees
112
News stories
From web sources and news partners
Investing.com
·
3 hours ago
Jefferies raises Inovio stock price target on regulatory win
Investing.com
·
4 hours ago
Why is Inovio Pharmaceuticals stock plunging today?
BigGo Finance
·
4 hours ago
Inovio Shares Sink 25% After $75 Million Stock Sale Priced at $1.05
Benzinga
·
9 hours ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com